Somatostatin receptor subtype 2 in high-grade gliomas: PET/CT with (68)Ga-DOTA-peptides, correlation to prognostic markers, and implications for targeted radiotherapy

BACKGROUND: High-grade gliomas (HGGs) express somatostatin receptors (SSTR), rendering them candidates for peptide receptor radionuclide therapy (PRRT). Our purpose was to evaluate the potential of (68)Ga-DOTA-1-Nal(3)-octreotide ((68)Ga-DOTANOC) or (68)Ga-DOTA-Tyr(3)-octreotide ((68)Ga-DOTATOC) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiviniemi, Aida, Gardberg, Maria, Frantzén, Janek, Pesola, Marko, Vuorinen, Ville, Parkkola, Riitta, Tolvanen, Tuula, Suilamo, Sami, Johansson, Jarkko, Luoto, Pauliina, Kemppainen, Jukka, Roivainen, Anne, Minn, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420768/
https://www.ncbi.nlm.nih.gov/pubmed/25977882
http://dx.doi.org/10.1186/s13550-015-0106-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420768/
https://www.ncbi.nlm.nih.gov/pubmed/25977882
http://dx.doi.org/10.1186/s13550-015-0106-2

Ejemplares similares